Bionetide

N/A

Report date: 2026/04/07 20:00:20

NME

Base Information

Drug NameBionetide

Drug Alias NameNA-921

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsInsulin-like growth factor I receptor agonists

TargetsGlucagon-like peptide 1 receptorInsulin-like growth factor I receptor

Therapy Area/IndicationsRett SyndromeFragile X Syndrome

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustralia

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsRett SyndromeFragile X Syndrome

Inactive IndicationsN/A

ATC CodeN/A